Gender gap in lipid management amongst diabetes population: an observation.

Studies have consistently demonstrated that women with diabetes are more likely than men to have a LDL-C above treatment goals. However, this pattern of gender gap has not been observed in many studies for HgbA1c goal attainment. Although the reasons for this are not fully understood, intolerance to statin therapy in women due to differences in pharmacodynamics and pharmacokinetics may play a role as female sex and aging has been associated with statin-associated myopathy. The concept of gender gap is useful for identifying at-risk groups for prevention and treatment efforts.